4//SEC Filing
Makela Jan 4
Accession 0001628280-24-023668
CIK 0001932393other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 7:15 PM ET
Size
21.9 KB
Accession
0001628280-24-023668
Insider Transaction Report
Form 4
Makela Jan
CEO, Imaging
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2024-05-15$63.51/sh+8,388$532,722→ 71,736 total - Sale
Common Stock, par value $0.01 per share
2024-05-15$81.54/sh−66,955$5,459,511→ 63,348 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-15−8,388→ 0 totalExercise: $63.51Exp: 2030-03-02→ Common Stock, par value $0.01 per share (8,388 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-15−33,095→ 33,096 totalExercise: $76.37Exp: 2031-07-01→ Common Stock, par value $0.01 per share (33,095 underlying) - Exercise/Conversion
Common Stock, par value $0.01 per share
2024-05-13$63.51/sh+20,227$1,284,617→ 83,575 total - Sale
Common Stock, par value $0.01 per share
2024-05-13$81.57/sh−20,227$1,649,916→ 63,348 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2024-05-15$75.30/sh+25,472$1,918,042→ 97,208 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2024-05-15$76.37/sh+33,095$2,527,465→ 130,303 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-13−20,227→ 8,388 totalExercise: $63.51Exp: 2030-03-02→ Common Stock, par value $0.01 per share (20,227 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-15−25,472→ 0 totalExercise: $75.30Exp: 2033-03-01→ Common Stock, par value $0.01 per share (25,472 underlying)
Footnotes (5)
- [F1]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- [F3]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023.
- [F4]Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024.
- [F5]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.
Documents
Issuer
GE HealthCare Technologies Inc.
CIK 0001932393
Entity typeother
Related Parties
1- filerCIK 0001951803
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 7:15 PM ET
- Size
- 21.9 KB